spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  hormone therapy 

 HSMN NewsFeed - 16 Feb 2023
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 6 May 2021
GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients
Diagnostics Radiology Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2020
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 29 Apr 2019
U.S. FDA Accepts New Drug Application and Grants Priority Review for Darolutamide
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Feb 2019
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2018
GenomeDx Announces Medicare Draft Local Coverage Determination (LCD) for Decipher Prostate Biopsy Genomic Classifier
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 2 Jul 2018
Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 10 Nov 2016
IBRANCE(R) (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2016
Pfizer to Acquire Medivation
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 Jul 2016
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2016
Bayer and Orion Expand Clinical Development Program for BAY-1841788 (ODM-201) in Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Feb 2016
Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Jun 2015
Vaxil's Lead Product ImMucin has Been Granted an Orphan Drug Designation by the FDA for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Mar 2014
Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN(R) In Very Young Children Born Small For Gestational Age
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 30 Jan 2014
Novo Nordisk Promotes Eddie Williams to Senior Vice President
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 4 Dec 2013
TherapeuticsMD Appoints Joel S. Krasnow, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Aug 2013
Novo Nordisk receives U.S. FDA clearance for the insulin injection device NovoPen Echo(R)
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 13 Feb 2013
Prostate Cancer Patients Treated with Proton Therapy at Loma Linda University Medical Center Show Excellent Quality of Life
Devices Oncology
 HSMN NewsFeed - 22 May 2012
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 27 Apr 2012
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2012
FDA Approves Levemir(R) Pregnancy Category Change for Women with Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 28 Feb 2012
FIRMAGON(R) (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in prostate cancer patients while providing better relief from lower urinary tract symptoms
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 21 Apr 2011
Novo Nordisk Announces U.S. Launch of NovoTwist(R) for Use with Levemir(R) FlexPen(R), NovoLog(R) FlexPen(R) and Victoza(R) Pen Devices
Devices Drug Delivery Endocrinology
 HSMN NewsFeed - 8 Dec 2010
Bavarian Nordic Receives Special Protocol Assessment Agreement From the FDA for Phase 3 Trial of PROSTVAC(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Nov 2010
FDA Approves Bionovo's Clinical Development Plan for Menerba
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2010
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem(R) 10 mcg
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 19 Oct 2009
Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jul 2009
FDA Approves NovoLog(R) Labeling Update
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 22 Jun 2009
Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2009
Novo Nordisk: New study directly comparing insulin delivery devices shows that Next Generation FlexPen has a significantly lower injection force than SoloStar and KwikPen
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 2 Apr 2009
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2008
Femara(R) (letrozole) FIRST Aromatase Inhibitor to Indicate Overall Survival Benefit Versus tamoxifen When Taken for Five Years After Breast Cancer Surgery
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Dec 2008
Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 8 Oct 2008
One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jul 2008
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 31 May 2008
Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Premenopausal Women With Early-Stage Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2008
Phase 3 GATTEX(TM) Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 13 May 2008
FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Apr 2008
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Mar 2008
New Study Backs use of Gene-Based Urine Test in Prostate Cancer
Diagnostics Oncology Urology
 HSMN NewsFeed - 17 Mar 2008
NPS Reports Successful GATTEX(TM) Extension Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Feb 2008
NPS Pharmaceuticals Announces Senior Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2008
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jan 2008
Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2008
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2008
Noven Announces Changes to Board of Directors and Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 13 Nov 2007
Pfizer and Nektar Reach Agreement on Exubera(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 30 Oct 2007
Minnesota Hormone Therapy Lawsuit Dismissed
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 Oct 2007
Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Sep 2007
BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2007
Bioenvision Provides Evoltra(R) (clofarabine) Regulatory Update
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Jul 2007
Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2007
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Jun 2007
BioSante Pharmaceuticals Announces the Commercial Launch of Elestrin(TM)
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2007
FDA Approves Divigel(R) (estradiol gel) 0.1 Percent for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 May 2007
Dendreon Announces FDA Confirms Data Required for Provenge(R) Licensure
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2007
Outcomes Data Continue to Demonstrate Value of Cytogen's PROSTASCINT(R) to Predict Prognosis in Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 May 2007
Additional Satraplatin Efficacy Data From Phase 3 SPARC Trial Presented at Annual Meeting of American Urological Association
Biopharmaceuticals Oncology Urology
 HSMN NewsFeed - 15 May 2007
Wyeth Wins Philadelphia Hormone Therapy Trial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 May 2007
Spectrum Pharmaceuticals Announces FDA'S Oncology Drug Advisory Committee to Review Satraplatin for the Treatment of Hormone Refractory Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2007
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Apr 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Apr 2007
Wyeth Responds to Special Report Published in New England Journal of Medicine
 HSMN NewsFeed - 16 Apr 2007
FDA Accepts Satraplatin NDA And Grants Priority Review
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Mar 2007
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2007
Novo Nordisk Appoints Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2007
Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2007
Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at the American Society of Clinical Oncology Prostate Cancer Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Feb 2007
GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Feb 2007
GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Feb 2007
Spectrum Pharmaceuticals Announces Completion of NDA Filing for Satraplatin for Hormone Refractory Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Feb 2007
Bioenvision Files with EMeA for Label Extension of Evoltra(R)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Feb 2007
British Journal of Urology Demonstrates Ablatherm Success for Late Stage Prostate Cancer Therapy
Devices Oncology
 HSMN NewsFeed - 5 Feb 2007
Bioenvision Appoints General Manager in Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2007
Novo Nordisk Appoints Nathaniel Clark, M.D., as Senior Medical Advisor - Diabetes
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 28 Dec 2006
BioSante Pharmaceuticals Initiates Phase III Study of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Dec 2006
Bioenvision Provides Update on Evoltra(R) European Regulatory Activities
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Dec 2006
Altus Pharmaceuticals Enters into Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Products for Growth Hormone Deficient Patients
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Dec 2006
BioSante Pharmaceuticals Receives FDA Approval of Bio-E-Gel(R) (estradiol gel), to be Marketed as Elestrin(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2006
Novo Nordisk to Pursue Lawsuit Despite Preliminary Injunction Denial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 11 Dec 2006
New Evoltra(R) Data Shows Impressive Response and Survival Rates
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Nov 2006
Bioenvision Appoints James S. Scibetta as New CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2006
Plan B(R) OTC Now Available in Pharmacies Nationwide
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2006
Cellgate Commences Phase II Clinical Trial of Anticancer Compound CGC-11047 for Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Oct 2006
Bioenvision Names Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2006
NovoSeven(R) Becomes First and Only Recombinant Therapy for Treatment of Rare, Life-Threatening Bleeding Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Oct 2006
Wyeth Responds to Mistrial in Philadelphia Hormone Therapy Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 24 Sep 2006
Spectrum Pharmaceuticals Announces Positive Results of Satraplatin Pivotal Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2006
Pharmion Corporation and GPC Biotech Announce Positive Results from the Satraplatin Pivotal Phase 3 Trial and Achievement of the Progression-Free Survival Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2006
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Sep 2006
Bioenvision to Expand into Japan and Southeast Asia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Sep 2006
Bioenvision to Formally Launch Evoltra(R) Throughout Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Sep 2006
Bioenvision's Suvus(TM) Lowers Viral Load in Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2006
Novo Nordisk Sues Pfizer for Patent Infringement
Biopharmaceuticals Endocrinology Drug Delivery Litigation
 HSMN NewsFeed - 27 Jun 2006
Novo Nordisk Prevails in sanofi-aventis Challenge to Levemir(R) - Up to 24 Hours Duration of Action and Other Claims Upheld
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Jun 2006
Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2006
New Survival Data on Evoltra(TM) (Clofarabine) in Elderly AML Reported at European Hematology Association Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2006
International Trade Commission Acts on Novo Nordisk Complaint: Launches Investigation of sanofi-aventis
Devices Biopharmaceuticals Drug Delivery Litigation
 HSMN NewsFeed - 5 Jun 2006
Bioenvision's Evoltra(TM) (clofarabine) Prolongs Survival in Elderly AML Patients with Adverse Cytogenetics
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2006
Serum HER-2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy
Oncology Diagnostics
 HSMN NewsFeed - 31 May 2006
NeoRx Corporation (Poniard Pharmaceuticals) Announces Treatment of First Patient With Picoplatin in Phase 1/2 Front-Line Prostate Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2006
Bioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R)
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 15 May 2006
Novo Nordisk Announces New Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2006
Novo Nordisk Appoints Edward Williams as Vice President of Biopharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2006
Wyeth Comments on New Report From The Nurses' Health Study Published Today in the Archives of Internal Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 May 2006
OncoGenex Announces Encouraging Data from a Phase I Study of Patients with Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Apr 2006
Cytogen and Savient Finalize Exclusive Distribution Agreement for SOLTAMOX(TM)
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 19 Apr 2006
BioSante Pharmaceuticals Announces FDA Filing and Review of NDA for Bio-E-Gel(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Apr 2006
New Data From the Women's Health Initiative Study Show No Increased Risk of Breast Cancer with Conjugated Estrogens Alone
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Apr 2006
Bioenvision's Evoltra(R) Achieves High Response Rates in Adult AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2006
New Long-Acting Insulin Analog Levemir(R) Now Available in United States
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Mar 2006
ChondroGene reports on blood-based prostate cancer diagnostic test development
Diagnostics Oncology
 HSMN NewsFeed - 10 Mar 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(TM) Data at The International Society for the Study of Women's Sexual Health Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2006
BioSante Pharmaceuticals Comments on New Data from Women's Health Initiative Study Showing No Increased Coronary Heart Risk with Estrogen-Alone Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Feb 2006
BioSante Pharmaceuticals Announces Bio-E-Gel(TM) NDA Submission
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 13 Feb 2006
New Data from Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease with Conjugated Estrogens Alone In Any Age Group Studied
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2006
Antares Pharma Announces Appointment of Robert F. Apple as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2006
Noven Provides Update on Vivelle-Dot(TM) Estrogen Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Jan 2006
Novo Nordisk Introduces New Storage Flexibility for Norditropin(R)
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2006
BioSante Pharmaceuticals Strengthens Management and Reaffirms Bio-E-Gel(TM) NDA Filing Guidance
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2006
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Jan 2006
Antares Completes the Phase II Clinical Trial for Anturol(TM)
Biopharmaceuticals Drug Delivery
Return to NewsFeed  

 Additional items found! 231

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 231 additional stories matching:
hormone therapy
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.